(BTI) British American Tobacco - Ratings and Ratios
Cigarettes, Vapour, Heated, Oral, Snus
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.22% |
| Yield on Cost 5y | 11.73% |
| Yield CAGR 5y | 0.10% |
| Payout Consistency | 89.1% |
| Payout Ratio | 2.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.0% |
| Value at Risk 5%th | 31.3% |
| Relative Tail Risk | -4.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.30 |
| Alpha | 67.17 |
| CAGR/Max DD | 1.27 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.481 |
| Beta | 0.073 |
| Beta Downside | 0.121 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.65% |
| Mean DD | 7.72% |
| Median DD | 7.26% |
Description: BTI British American Tobacco December 02, 2025
British American Tobacco p.l.c. (NYSE: BTI) is a global tobacco and nicotine company that markets a broad portfolio-including combustible cigarettes, vapour, heated-tobacco, and modern oral nicotine products-through well-known brands such as Vuse, glo, Velo, Camel, Dunhill and Lucky Strike. Its distribution network spans the Americas, Europe, Asia-Pacific, the Middle East, Africa and the United States, and the firm is headquartered in London, United Kingdom.
Key recent metrics: FY 2023 net revenue was $27.3 billion, with an adjusted operating margin of 31 %-the highest in the sector, driven largely by a ~15 % share of next-generation products (NGPs) in total sales, which grew ≈ 20 % YoY. The company’s free-cash-flow conversion remains above 70 %, supporting its £2 billion annual dividend. Sector-level drivers include declining smoking prevalence in high-income markets (≈ −2 % p.a.) and tightening regulation, which is accelerating the shift toward higher-margin NGPs and price-elastic premium pricing strategies.
For a deeper, data-rich assessment of BTI’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -10.75b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 6.47 > 1.0 |
| NWC/Revenue: -4.10% < 20% (prev -4.31%; Δ 0.22% < -1%) |
| CFO/TA 0.15 > 3% & CFO 16.29b > Net Income -10.75b |
| Net Debt (-4.40b) to EBITDA (20.68b): -0.21 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.21b) vs 12m ago -1.14% < -2% |
| Gross Margin: 82.49% > 18% (prev 0.74%; Δ 8176 % > 0.5%) |
| Asset Turnover: 45.23% > 50% (prev 29.04%; Δ 16.19% > 0%) |
| Interest Coverage Ratio: 3.79 > 6 (EBITDA TTM 20.68b / Interest Expense TTM 4.30b) |
Altman Z'' 2.29
| A: -0.02 (Total Current Assets 13.88b - Total Current Liabilities 16.00b) / Total Assets 110.23b |
| B: 0.21 (Retained Earnings 22.99b / Total Assets 110.23b) |
| C: 0.14 (EBIT TTM 16.31b / Avg Total Assets 114.47b) |
| D: 0.74 (Book Value of Equity 46.75b / Total Liabilities 63.05b) |
| Altman-Z'' Score: 2.29 = BBB |
Beneish M -3.34
| DSRI: 0.61 (Receivables 3.48b/3.79b, Revenue 51.78b/34.48b) |
| GMI: 0.90 (GM 82.49% / 73.90%) |
| AQI: 0.99 (AQ_t 0.84 / AQ_t-1 0.84) |
| SGI: 1.50 (Revenue 51.78b / 34.48b) |
| TATA: -0.25 (NI -10.75b - CFO 16.29b) / TA 110.23b) |
| Beneish M-Score: -3.34 = AA |
ValueRay F-Score (Strict, 0-100) 82.54
| 1. Piotroski: 5.50pt |
| 2. FCF Yield: 14.92% |
| 3. FCF Margin: 36.14% |
| 4. Debt/Equity: 0.75 |
| 5. Debt/Ebitda: -0.21 |
| 6. ROIC - WACC: 21.62% |
| 7. RoE: -20.99% |
| 8. Revenue Trend: 55.30% |
| 9. EPS Trend: 13.29% |
What is the price of BTI shares?
Over the past week, the price has changed by +1.61%, over one month by +5.10%, over three months by +15.62% and over the past year by +69.84%.
Is BTI a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59.5 | 0.6% |
| Analysts Target Price | 59.5 | 0.6% |
| ValueRay Target Price | 77.5 | 31% |
BTI Fundamental Data Overview January 19, 2026
P/E Trailing = 31.3011
P/E Forward = 11.9474
P/S = 4.9586
P/B = 2.0154
P/EG = 0.4177
Revenue TTM = 51.78b GBP
EBIT TTM = 16.31b GBP
EBITDA TTM = 20.68b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.30b GBP (from shortTermDebt, last quarter)
Debt = 35.33b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.40b GBP (from netDebt column, last quarter)
Enterprise Value = 125.40b GBP (94.48b + Debt 35.33b - CCE 4.40b)
Interest Coverage Ratio = 3.79 (Ebit TTM 16.31b / Interest Expense TTM 4.30b)
EV/FCF = 6.70x (Enterprise Value 125.40b / FCF TTM 18.71b)
FCF Yield = 14.92% (FCF TTM 18.71b / Enterprise Value 125.40b)
FCF Margin = 36.14% (FCF TTM 18.71b / Revenue TTM 51.78b)
Net Margin = -20.75% (Net Income TTM -10.75b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Gross Margin QoQ = 83.59% (prev 83.20%)
Tobins Q-Ratio = 1.14 (Enterprise Value 125.40b / Total Assets 110.23b)
Interest Expense / Debt = 2.16% (Interest Expense 764.0m / Debt 35.33b)
Taxrate = 18.10% (1.01b / 5.57b)
NOPAT = 13.36b (EBIT 16.31b * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.75 (Debt 35.33b / totalStockholderEquity, last quarter 46.87b)
Debt / EBITDA = -0.21 (Net Debt -4.40b / EBITDA 20.68b)
Debt / FCF = -0.24 (Net Debt -4.40b / FCF TTM 18.71b)
Total Stockholder Equity = 51.18b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.39% (Net Income -10.75b / Total Assets 110.23b)
RoE = -20.99% (Net Income TTM -10.75b / Total Stockholder Equity 51.18b)
RoCE = 19.63% (EBIT 16.31b / Capital Employed (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 26.60% (NOPAT 13.36b / Invested Capital 50.21b)
WACC = 4.98% (E(94.48b)/V(129.80b) * Re(6.18%) + D(35.33b)/V(129.80b) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.57%
[DCF Debug] Terminal Value 87.27% ; FCFF base≈16.22b ; Y1≈17.92b ; Y5≈23.17b
Fair Price DCF = 316.9 (EV 683.71b - Net Debt -4.40b = Equity 688.12b / Shares 2.17b; r=5.90% [WACC]; 5y FCF grow 12.09% → 2.90% )
EPS Correlation: 13.29 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 55.30 | Revenue CAGR: -2.95% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=4.87 | Chg30d=+0.079 | Revisions Net=-2 | Growth EPS=+5.7% | Growth Revenue=+2.9%
Additional Sources for BTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle